Pfizer Went From Covid Star to Activist Target
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
Pfizer taps Triana to discover molecular glues for cancer and beyond in deal potentially worth $1.5B
Big Pharma is sticking to the recent molecular glue investment trend, with Pfizer now the latest major drugmaker to get in on ...
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback